Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Carbidopa and levodopa is a prescription combination used for Parkinson disease and parkinsonian syndromes. Levodopa is a metabolic precursor of dopamine, while carbidopa inhibits peripheral breakdown of levodopa. Immediate-release tablets commonly contain 10 mg with 100 mg, 25 mg with 100 mg, or 25 mg with 250 mg of carbidopa and levodopa.
read more about carbidopa and levodopa ...Levodopa crosses the blood-brain barrier and is converted to dopamine in the brain, helping replace deficient dopamine activity. Carbidopa does not cross the blood-brain barrier to a substantial degree and inhibits peripheral levodopa decarboxylation. This sends more levodopa to the brain and reduces peripheral reactions such as nausea and vomiting.
Carbidopa and levodopa tablets are used for Parkinson disease and parkinsonian syndromes. The combination can treat parkinsonism that follows encephalitis or carbon monoxide or manganese intoxication. Dosing is individualized according to symptoms, prior levodopa exposure, response, and adverse reactions.
Immediate-release treatment commonly starts with one 25 mg with 100 mg tablet three times daily. The dose can increase by one tablet every day or every other day according to response, up to eight 25 mg with 100 mg tablets daily under the usual schedule. Vitamin B6 levels are evaluated before and during treatment.
Carbidopa and levodopa can cause sudden sleep episodes, sleepiness, dyskinesia, hallucinations, psychotic-like behavior, compulsive behaviors, and low blood pressure. Rapid dose reduction or withdrawal can trigger high fever, muscle rigidity, confusion, and autonomic instability. Current labeling also warns about vitamin B6 deficiency and associated seizures during treatment.
Carbidopa reduces peripheral levodopa breakdown, sending more levodopa to the brain and reducing peripheral reactions.
The combination is used for Parkinson disease and selected parkinsonian syndromes.
A common starting regimen is one 25 mg with 100 mg tablet three times daily.
Yes. Sudden sleep during daily activities has been reported, sometimes without warning.
Carbidopa. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK554552/. Date Accessed September 21, 2026.
DailyMed - CARBIDOPA AND LEVODOPA tablet, extended release. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0eb24333-3c11-41dd-888d-3a30d3c9d188. Date Accessed September 21, 2026.
DailyMed - CARBIDOPA-LEVODOPA (carbidopa and levodopa) tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e3c796b-2e68-4bcc-b927-18a58bea4703. Date Accessed September 21, 2026.
Levodopa and Carbidopa. MedlinePlus. https://medlineplus.gov/druginfo/meds/a601068.html. Date Accessed September 21, 2026.
SINEMET (carbidopa and levodopa) Tablets. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9b17b028-964a-473c-823d-81423535bd66. Date Accessed September 21, 2026.